Humanigen (NASDAQ:HGEN) Earns "Underperform" Rating from Credit Suisse Group
Credit Suisse Group reissued their underperform rating on shares of Humanigen (NASDAQ:HGEN – Get Rating) in a research note released on Monday, Benzinga reports. They currently have a $0.50 target price on the stock. Separately, Cantor Fitzgerald initiated coverage on shares of Humanigen in a research note on Wednesday, January 11th. They set a neutral […]